Article Details

Small Pharma stock market launch funds DMT-based depression drug trial

Retrieved on: 2021-05-07 09:54:46

Tags for this article:

Click the tags to see associated articles and topics

Small Pharma stock market launch funds DMT-based depression drug trial. View article details on hiswai:

Excerpt

UK-based Small Pharma has launched on the Toronto's TSX Venture Exchange, raising 63 million Canadian dollars (around £37m) to develop ...

Article found on: pharmaphorum.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo